Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)Dung T. Le, Elizabeth M. Jaffee, Vincent J. Picozzi et al.|Clinical Cancer Research|2019Cited by 260
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic CancerTakahiro Tsujikawa, Dung T. Le, Elana J. Fertig et al.|Clinical Cancer Research|2020Cited by 151
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J. Jackson, Mikhail Zibinsky, Grant M. Shibuya et al.|Journal of Medicinal Chemistry|2022Cited by 12
Abstract 2654: HPK1 inhibits CD8+ T cell effector gene expression following T cell activationRachel Y. Ames, Dirk G. Brockstedt, Rongqi Zhao et al.|Cancer Research|2024Cited by 0